Rajesh Krishnan
Vice President, Delivery Technology & Development Providence Therapeutics
Seminars
Tuesday 21st July 2026
A Point-of-Care LNP Formulation for Rapid Manufacturing of Personalized Cancer Vaccines
12:30 pm
- Showcasing an off‑the‑shelf lipid nanoparticle platform, eliminating the need for bespoke formulation development
- Personalized vaccines are rapidly manufactured by simply incorporating patient‑specific mRNAs
- This modular approach dramatically shortens manufacturing timelines and significantly lowers production costs for personalized cancer vaccines
